ХРОНИЧЕСКИЕ ВОСПАЛИТЕЛЬНЫЕ ЗАБОЛЕВАНИЯ ПЛАЦЕНТЫ, АССОЦИИРОВАННЫЕ С РЕЦИДИВИРУЮЩИМИ НЕБЛАГОПРИЯТНЫМИ ИСХОДАМИ БЕРЕМЕННОСТИ
Abstract
Данная работа посвящена анализу трёх тесно взаимосвязанных хронических воспалительных патологий плаценты: виллиту неизвестной этиологии (ВУЭ), хроническому гистиоцитарному интервиллезиту (ХГИ) и массивному перивиллезному отложению фибрина (МПФД). Эти заболевания характеризуются выраженной инфильтрацией плацентарной ткани материнскими иммунокомпетентными клетками и структурным нарушением межворсинчатого пространства, где осуществляется газообмен между организмом матери и плода. Подобные воспалительные процессы играют ключевую роль в нарушении плацентарной перфузии, формировании фетоплацентарной недостаточности и развитии неблагоприятных перинатальных исходов.
References
1. Heazell AE, Siassakos D, Blencowe H, Burden C, Bhutta ZA, Cacciatore J, et al. Stillbirths: Economic and Psychosocial Consequences. Lancet (2016) 387(10018):604–16. doi: 10.1016/S0140-6736(15)00836-3
2. Farren J, Mitchell-Jones N, Verbakel JY, Timmerman D, Jalmbrant M, Bourne T. The Psychological Impact of Early Pregnancy Loss. Hum Reprod Update (2018) 24(6):731–49. doi: 10.1093/humupd/dmy025
3. Petrou S, Yiu HH, Kwon J. Economic Consequences of Preterm Birth: A Systematic Review of the Recent Literature (2009-2017). Arch Dis Child (2019) 104(5):456–65. doi: 10.1136/archdischild-2018-315778
4. Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, et al. Stillbirths: Recall to Action in High-Income Countries. Lancet (2016) 387(10019):691–702. doi: 10.1016/S0140-6736(15)01020-X
5. NHS England. Saving Babies’ Lives Version Two: A Care Bundle for Reducing Perinatal Mortality (2019). Available at: https://www.england.nhs.uk/wp-content/uploads/2019/03/Saving-Babies-Lives-Care-Bundle-Version-TwoUpdated-Final-Version.pdf.
6. Man J, Hutchinson JC, Heazell AE, Ashworth M, Levine S, Sebire NJ. Stillbirth and Intrauterine Fetal Death: Factors Affecting Determination of Cause of Death at Autopsy. Ultrasound Obstet Gynecol (2016) 48(5):566–73. doi: 10.1002/uog.16016
7. Man J, Hutchinson JC, Heazell AE, Ashworth M, Jeffrey I, Sebire NJ. Stillbirth and Intrauterine Fetal Death: Role of Routine Histopathological Placental Findings to Determine Cause of Death. Ultrasound Obstet Gynecol (2016) 48(5):579–84. doi: 10.1002/uog.16019
8. Kim CJ, Romero R, Chaemsaithong P, Kim JS. Chronic Inflammation of the Placenta: Definition, Classification, Pathogenesis, and Clinical Significance. Am J Obstet Gynecol (2015) 213(4 Suppl):S53–69. doi: 10.1016/j.ajog.2015.08.041
9. Simula NK, Terry J, Kent NE, Robertson J, Purkiss S, Bloomenthal D, et al. Chronic Intervillositis of Unknown Etiology (CIUE): Prevalence, Patterns and Reproductive Outcomes at a Tertiary Referral Institution. Placenta (2020) 100:60–5. doi: 10.1016/j.placenta.2020.07.032
10. Chen A, Roberts DJ. Placental Pathologic Lesions With a Significant Recurrence Risk - What Not to Miss! APMIS (2018) 126(7):589–601. doi: 10.1111/apm.12796
11. Brady CA, Williams C, Sharps MC, Shelleh A, Batra G, Heazell AEP, et al. Chronic Histiocytic Intervillositis: A Breakdown in Immune Tolerance Comparable to Allograft Rejection? Am J Reprod Immunol (2020) 85(3):e13373. doi: 10.1111/aji.13373
12. Bos M, Harris-Mostert E, van der Meeren LE, Baelde JJ, Williams DJ, Nikkels PGJ, et al. Clinical Outcomes in Chronic Intervillositis of Unknown Etiology. Placenta (2020) 91:19–23. doi: 10.1016/j.placenta.2020.01.001
13. Heller DS. CD68 Immunostaining in the Evaluation of Chronic Histiocytic Intervillositis. Arch Pathol Lab Med (2012) 136(6):657–9. doi: 10.5858/arpa.2011-0328-OA
14. Redline RW. Extending the Spectrum of Massive Perivillous Fibrin Deposition (Maternal Floor Infarction). Pediatr Dev Pathol (2021) 24(1):10–1. doi: 10.1177/1093526620964353
15. Bos M, Nikkels PGJ, Cohen D, Schoones JW, Bloemenkamp KWM, Bruijn JA, et al. Towards Standardized Criteria for Diagnosing Chronic Intervillositis of Unknown Etiology: A Systematic Review. Placenta (2018) 61:80–8. doi: 10.1016/j.placenta.2017.11.012
16. Ongaro D, Terry J. Reproducibility of Grading in Chronic Intervillositis of Unknown Etiology. Pediatr Dev Pathol (2020) 23(3):210–4. doi: 10.1177/1093526619882522
17. Nowak C, Joubert M, Jossic F, Masseau A, Hamidou M, Philippe HJ, et al. Perinatal Prognosis of Pregnancies Complicated by Placental Chronic Villitis or Intervillositis of Unknown Etiology and Combined Lesions: About a Series of 178 Cases. Placenta (2016) 44:104–8. doi: 10.1016/j.placenta.2016.04.017
18. Iskender C, Zergeroglu S, Kaymak O, Celen S, Danisman N. Villitis of Unknown Aetiology: Clinical Implications in Preterm Population. J Obstet Gynaecol (2016) 36(2):192–5. doi: 10.3109/01443615.2015.1036410
19. Kovo M, Ganer Herman H, Gold E, Bar J, Schreiber L. Villitis of Unknown Etiology - Prevalence and Clinical Associations. J Matern Fetal Neonatal Med (2016) 29(19):3110–4. doi: 10.3109/14767058.2015.1114090
20. Devisme L, Chauviere C, Franquet-Ansart H, Chudzinski A, Stichelbout M, Houfflin-Debarge V, et al. Perinatal Outcome of Placental Massive Perivillous Fibrin Deposition: A Case-Control Study. Prenat Diagn (2017) 37(4):323–8. doi: 10.1002/pd.5013
21. Freedman AA, Miller GE, Ernst LM. Chronic Villitis: Refining the Risk Ratio of Recurrence Using a Large Placental Pathology Sample. Placenta (2021) 112:135–40. doi: 10.1016/j.placenta.2021.07.298
22. Mattuizzi A, Sauvestre F, Andre G, Poingt M, Camberlein C, Carles D, et al. Adverse Perinatal Outcomes of Chronic Intervillositis of Unknown Etiology: An Observational Retrospective Study of 122 Cases. Sci Rep (2020) 10(1):12611. doi: 10.1038/s41598-020-69191-9
23. Parant O, Capdet J, Kessler S, Aziza J, Berrebi A. Chronic Intervillositis of Unknown Etiology (CIUE): Relation Between Placental Lesions and Perinatal Outcome. Eur J Obstet Gynecol Reprod Biol (2009) 143(1):9–13. doi: 10.1016/j.ejogrb.2008.06.012
24. Forger F, Villiger PM. Immunological Adaptations in Pregnancy That Modulate Rheumatoid Arthritis Disease Activity. Nat Rev Rheumatol (2020) 16(2):113–22. doi: 10.1038/s41584-019-0351-2
25. Aghaeepour N, Ganio EA, McIlwain D, Tsai AS, Tingle M, Van Gassen S, et al. An Immune Clock of Human Pregnancy. Sci Immunol (2017) 2(15):1–11. doi: 10.1126/sciimmunol.aan2946
26. Gregori S, Amodio G, Quattrone F, Panina-Bordignon P. HLA-G Orchestrates the Early Interaction of Human Trophoblasts With the Maternal Niche. Front Immunol (2015) 6:128. doi: 10.3389/fimmu.2015.00128
27. Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-Hernandez M. Immune Cells in Term and Preterm Labor. Cell Mol Immunol (2014) 11(6):571–81. doi: 10.1038/cmi.2014.46
28. Traeder J, Jonigk D, Feist H, Brocker V, Langer F, Kreipe H, et al. Pathological Characteristics of a Series of Rare Chronic Histiocytic Intervillositis of the Placenta. Placenta (2010) 31(12):1116–9. doi: 10.1016/j.placenta.2010.09.012
29. Pathak S, Lees CC, Hackett G, Jessop F, Sebire NJ. Frequency and Clinical Significance of Placental Histological Lesions in an Unselected Population at or Near Term. Virchows Arch (2011) 459(6):565–72. doi: 10.1007/s00428-011-1157-z
30. Romero R, Kim YM, Pacora P, Kim CJ, Benshalom-Tirosh N, Jaiman S, et al. The Frequency and Type of Placental Histologic Lesions in Term Pregnancies With Normal Outcome. J Perinat Med (2018) 46(6):613–30. doi: 10.1515/jpm-2018-0055
31. Marchaudon V, Devisme L, Petit S, Ansart-Franquet H, Vaast P, Subtil D. Chronic Histiocytic Intervillositis of Unknown Etiology: Clinical Features in a Consecutive Series of 69 Cases. Placenta (2011) 32(2):140–5. doi: 10.1016/j.placenta.2010.11.021
32. Homatter C, Stichelbout M, Devisme L, Chudzinski A, Debarge V, Garabedian C, et al. Is Chronic Histiocytic Intervillositis a Severe Placental Disease? A case-control study Placenta (2020) 91:31–6. doi: 10.1016/j.placenta.2019.12.020
33. Revaux A, Mekinian A, Nicaise P, Bucourt M, Cornelis F, Lachassinne E, et al. Antiphospholipid Syndrome and Other Autoimmune Diseases Associated With Chronic Intervillositis. Arch Gynecol Obstet (2015) 291(6):1229–36. doi: 10.1007/s00404-014-3536-6
